Terms: = Colorectal cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862
862 results:
1. [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation].
Zan LK; Shen LL; Zhang X; Gao N; Tian BG; Geng XX; Peng X; Li JW; Bu P; Zhao GH
Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):686-695. PubMed ID: 39034804
[No Abstract] [Full Text] [Related]
2. Unveiling the oncogenic role of LZTS1 in colorectal cancer.
Xu Y; Pepe D; Yao S; Boudhan L; Verbandt S; Pu T; Creemers JWM; Liu M; Tejpar S; He Z; Zhu J; Wang Y
J Cell Mol Med; 2024 Jul; 28(14):e18441. PubMed ID: 39023696
[TBL] [Abstract] [Full Text] [Related]
3. Genetic Insights into colorectal cancer: Evaluating PI3K/AKT Signaling Pathway Genes Expression.
Świechowski R; Pietrzak J; Wosiak A; Mik M; Balcerczak E
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891994
[TBL] [Abstract] [Full Text] [Related]
4. Specific and efficient knockdown of intracellular miRNA using partially neutralized phosphate-methylated DNA oligonucleic acid-loaded mesoporous silica nanoparticles.
Sung YJ; Cai WT; Chen YP; Chan HW; Lin CK; Wang PH; Chen WY
J Mater Chem B; 2024 Jul; 12(26):6492-6499. PubMed ID: 38872610
[TBL] [Abstract] [Full Text] [Related]
5. Prevalence of Potentially Pathogenic Germline Variants Among Adult Patients in the Philippines With Solid Malignancies Who Underwent Tumor Genomic Profiling.
Franco PI; Andal JJ; Ang DC; Que FV
JCO Glob Oncol; 2024 Jun; 10():e2400019. PubMed ID: 38843470
[TBL] [Abstract] [Full Text] [Related]
6. [Incidence of common gene mutations in early-onset colorectal cancer and the association with cancer survival: a meta-analysis].
Zhang RQ; Li SH; Hu TJ; Xu LY; Zhu YS; Li X
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):495-506. PubMed ID: 38778689
[TBL] [Abstract] [Full Text] [Related]
7. pten and P-4E-BP1 might be associated with postoperative recurrence of rectal cancer patients undergoing concurrent radiochemotherapy.
Zhang H; Li X; Sun W; Qin H; Li H; Yan H; Wang H; Zhang X; Zhang S; Wang H
BMC Cancer; 2024 May; 24(1):582. PubMed ID: 38741069
[TBL] [Abstract] [Full Text] [Related]
8. BET inhibition induces synthetic lethality in pten deficient colorectal cancers via dual action on p21
Ren G; Chen J; Pu Y; Yang EJ; Tao S; Mou PK; Chen LJ; Zhu W; Chan KL; Luo G; Deng C; Shim JS
Int J Biol Sci; 2024; 20(6):1978-1991. PubMed ID: 38617536
[TBL] [Abstract] [Full Text] [Related]
9. SNHG4-mediated pten destabilization confers oxaliplatin resistance in colorectal cancer cells by inhibiting ferroptosis.
Li SQ; Xu WT; Yin YX; Wei HT; Li KZ; Xie MZ; Lv F; Xie LY; Hu BL
Apoptosis; 2024 Jun; 29(5-6):835-848. PubMed ID: 38573492
[TBL] [Abstract] [Full Text] [Related]
10. cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of pten and stimulating interleukin-6 production.
Ghofrani-Shahpar M; Pakravan K; Razmara E; Amooie F; Mahmoudian M; Heshmati M; Babashah S
BMC Cancer; 2024 Apr; 24(1):400. PubMed ID: 38561726
[TBL] [Abstract] [Full Text] [Related]
11. Baseline ctDNA gene alterations as a biomarker of survival after panitumumab and chemotherapy in metastatic colorectal cancer.
Shitara K; Muro K; Watanabe J; Yamazaki K; Ohori H; Shiozawa M; Takashima A; Yokota M; Makiyama A; Akazawa N; Ojima H; Yuasa Y; Miwa K; Yasui H; Oki E; Sato T; Naitoh T; Komatsu Y; Kato T; Mori I; Yamanaka K; Hihara M; Soeda J; Misumi T; Yamamoto K; Yamashita R; Akagi K; Ochiai A; Uetake H; Tsuchihara K; Yoshino T
Nat Med; 2024 Mar; 30(3):730-739. PubMed ID: 38347302
[TBL] [Abstract] [Full Text] [Related]
12. Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal cancers.
Ngoi NYL; Tang TY; Gaspar CF; Pavlick DC; Buchold GM; Scholefield EL; Parimi V; Huang RSP; Janovitz T; Danziger N; Levy MA; Pant S; De Armas AD; Kumpula D; Ross JS; Javle M; Rodon Ahnert J
Oncologist; 2024 Jun; 29(6):493-503. PubMed ID: 38330461
[TBL] [Abstract] [Full Text] [Related]
13. FBXO8 is a novel prognostic biomarker in different molecular subtypes of breast cancer and suppresses breast cancer progression by targeting c-MYC.
Khan AJ; Man S; Abbas M; Liu S; Zhang F
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130577. PubMed ID: 38301858
[TBL] [Abstract] [Full Text] [Related]
14. Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic colorectal cancer (PanaMa Phase II Trial, AIO KRK 0212).
Stahler A; Kind AJ; Sers C; Mamlouk S; Müller L; Karthaus M; Fruehauf S; Graeven U; Fischer von Weikersthal L; Sommerhäuser G; Kasper S; Hoppe B; Kurreck A; Held S; Heinemann V; Horst D; Jarosch A; Stintzing S; Trarbach T; Modest DP
Clin Cancer Res; 2024 Apr; 30(7):1256-1263. PubMed ID: 38289994
[TBL] [Abstract] [Full Text] [Related]
15. Knocking down of lncRNA SBF2-AS1 inhibits proliferation, invasion and induces apoptosis of colorectal cancer through regulating pten.
Cai Y; Yan H; Wang F; Xie L
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):201-205. PubMed ID: 38279439
[TBL] [Abstract] [Full Text] [Related]
16.
Battaglin F; Baca Y; Millstein J; Yang Y; Xiu J; Arai H; Wang J; Ou FS; Innocenti F; Mumenthaler SM; Jayachandran P; Kawanishi N; Lenz A; Soni S; Algaze S; Zhang W; Khoukaz T; Roussos Torres E; Seeber A; Abraham JP; Lou E; Philip PA; Weinberg BA; Shields AF; Goldberg RM; Marshall JL; Venook AP; Korn WM; Lenz HJ
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38212126
[TBL] [Abstract] [Full Text] [Related]
17. Clinical-Molecular characteristics and Post-Translational modifications of colorectal cancer in north China: Implications for future targeted therapies.
Chi Y; Yuan H; Fan Q; Wang Z; Niu Z; Yu J; Yuan D
Gene; 2024 Mar; 899():148134. PubMed ID: 38185290
[TBL] [Abstract] [Full Text] [Related]
18. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
19. De novo NAD
Wan J; Cheng C; Hu J; Huang H; Han Q; Jie Z; Zou Q; Shi JH; Yu X
Cell Rep; 2023 Dec; 42(12):113518. PubMed ID: 38041812
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
[TBL] [Abstract] [Full Text] [Related]
[Next]
